Transdermal Drug Delivery Systems Market Research Report – Forecast till 2027

Transdermal (Percutaneous) Drug Delivery Systems Market Research Report: by Product (Transdermal Patches, Semisolids), Technology (Electric Current, Iontophoresis, Electroporation, Ultrasound, Microporation), and Application (HRT) — Forecast till 2027

ID: MRFR/HC/6076-HCR | February, 2021 | Region : Global

Table of Contents:


Chapter 1. Report Prologue

Chapter 2. Market Introduction

2.1. Definition

2.2. Scope of the Study

2.2.1. Research Objective

2.2.2. Assumptions

2.2.3. Limitations

Chapter 3. Research Methodology

3.1. Introduction

3.2. Primary Research

3.3. Secondary Research

3.4. Market Size Estimation

Chapter 4. Market Dynamics

4.1. Drivers

4.2. Restraints

4.3. Opportunities

4.4. Challenges

4.5. Macroeconomic Indicators

4.6. Detection Technique Trends & Assessment

Chapter 5. Market Factor Analysis

5.1. Porter’s Five Forces Analysis

5.1.1. Bargaining Power of Suppliers

5.1.2. Bargaining Power of Buyers

5.1.3. Threat of New Entrants

5.1.4. Threat of Substitutes

5.1.5. Intensity of Rivalry

5.2. Value Chain Analysis

5.3. Investment Feasibility Analysis

5.4. Pricing Analysis

Chapter 6. Global Transdermal (Percutaneous) Drug Delivery Systems Market, by Product

6.1. Introduction

6.2. Transdermal Patches

6.2.1. Drug-in-adhesive Patches

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.2.2. Matrix Patches

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.2.3. Reservoir Membrane Patches

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.2.4. Microneedle Patches

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.3. Transdermal Semisolids

6.3.1. Gels

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.3.2. Ointments

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.3.3. Sprays

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

Chapter 7. Global Transdermal (Percutaneous) Drug Delivery Systems Market, by Technology

7.1. Introduction

7.2. Electric Current

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

7.3. Iontophoresis

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

7.4. Electroporation

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

7.5. Ultrasound

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

7.6. Microporation

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

7.7. Thermal

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

7.8. Others

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

Chapter 8. Global Transdermal (Percutaneous) Drug Delivery Systems Market, by Application

8.1. Introduction

8.2. Pain Management

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

8.3. Cardiovascular Diseases

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

8.4. Hormone Replacement Therapy

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

8.5. Central Nervous System Disorders

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

8.6. Smoking Cessation

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

8.7. Contraception

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

8.8. Others

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

Chapter 9. Global Transdermal (Percutaneous) Drug Delivery Systems Market, by Region

9.1. Introduction

9.2. Americas

9.2.1. North America

9.2.1.1. US

9.2.1.2. Canada

9.2.2. Latin America

9.3. Europe

9.3.1. Western Europe

9.3.1.1. Germany

9.3.1.2. France

9.3.1.3. Italy

9.3.1.4. Spain

9.3.1.5. UK

9.3.1.6. Rest of Western Europe

9.3.2. Eastern Europe

9.4. Asia-Pacific

9.4.1. Japan

9.4.2. China

9.4.3. India

9.4.4. Australia

9.4.5. South Korea

9.4.6. Rest of Asia-Pacific

9.5. Middle East & Africa

9.5.1. Middle East

9.5.2. Africa

Chapter 10. Company Landscape

10.1. Introduction

10.2. Market Share Analysis

10.3. Key Developments & Strategies

Chapter 11. Company Profiles

11.1. Mylan N.V.

11.1.1. Company Overview

11.1.2. Product Overview

11.1.3. Financial Overview

11.1.4. Key Developments

11.1.5. SWOT Analysis

11.1.6. Key Strategies

11.2. Hisamitsu Pharmaceutical Co., Inc.

11.2.1. Company Overview

11.2.2. Product Overview

11.2.3. Financial Overview

11.2.4. Key Developments

11.2.5. SWOT Analysis

11.2.6. Key Strategies

11.3. Novartis International AG

11.3.1. Company Overview

11.3.2. Product Overview

11.3.3. Financial Overview

11.3.4. Key Developments

11.3.5. SWOT Analysis

11.3.6. Key Strategies

11.4. Boehringer Ingelheim International GmbH

11.4.1. Company Overview

11.4.2. Product Overview

11.4.3. Financial Overview

11.4.4. Key Developments

11.4.5. SWOT Analysis

11.4.6. Key Strategies

11.5. GlaxoSmithKline Plc

11.5.1. Company Overview

11.5.2. Product Overview

11.5.3. Financial Overview

11.5.4. Key Developments

11.5.5. SWOT Analysis

11.5.6. Key Strategies

11.6. Johnson & Johnson Services, Inc.

11.6.1. Company Overview

11.6.2. Product Overview

11.6.3. Financial Overview

11.6.4. Key Developments

11.6.5. SWOT Analysis

11.6.6. Key Strategies

11.7. Endo Pharmaceuticals Inc.

11.7.1. Company Overview

11.7.2. Product Overview

11.7.3. Financial Overview

11.7.4. Key Developments

11.7.5. SWOT Analysis

11.7.6. Key Strategies

11.8. UCB S.A.

11.8.1. Company Overview

11.8.2. Product Overview

11.8.3. Financial Overview

11.8.4. Key Developments

11.8.5. SWOT Analysis

11.8.6. Key Strategies

11.9. Pfizer Inc.

11.9.1. Company Overview

11.9.2. Product Overview

11.9.3. Financial Overview

11.9.4. Key Developments

11.9.5. SWOT Analysis

11.9.6. Key Strategies

11.10. Allergan plc

11.10.1. Company Overview

11.10.2. Product Overview

11.10.3. Financial Overview

11.10.4. Key Developments

11.10.5. SWOT Analysis

11.10.6. Key Strategies

11.11. Actelion Pharmaceuticals Ltd

11.11.1. Company Overview

11.11.2. Product Overview

11.11.3. Financial Overview

11.11.4. Key Developments

11.11.5. SWOT Analysis

11.11.6. Key Strategies

11.12. Noven Pharmaceuticals, Inc.

11.12.1. Company Overview

11.12.2. Product Overview

11.12.3. Financial Overview

11.12.4. Key Developments

11.12.5. SWOT Analysis

11.12.6. Key Strategies

Chapter 12. MRFR Conclusion

12.1. Key Findings

12.1.1. From CEO’s Viewpoint

12.1.2. Unmet Needs of the Market

12.2. Key Companies to Watch

12.3. Predictions for the Transdermal (Percutaneous) Drug Delivery Systems Industry

Chapter 13. Appendix

LIST OF TABLES

Table 1. Global Transdermal (Percutaneous) Drug Delivery Systems Market Synopsis, 2020-2027

Table 2. Global Transdermal (Percutaneous) Drug Delivery Systems Market Estimates and Forecast, 2020-2027 (USD Million)

Table 3. Global Transdermal (Percutaneous) Drug Delivery Systems Market, by Region, 2020-2027 (USD Million)

Table 4. Global Transdermal (Percutaneous) Drug Delivery Systems Market, by Product, 2020-2027 (USD Million)

Table 5. Global Transdermal (Percutaneous) Drug Delivery Systems Market, by Technology, 2020-2027 (USD Million)

Table 6. Global Transdermal (Percutaneous) Drug Delivery Systems Market, by Application, 2020-2027 (USD Million)

Table 7. North America: Transdermal (Percutaneous) Drug Delivery Systems Market, by Product, 2020-2027 (USD Million)

Table 8. North America: Transdermal (Percutaneous) Drug Delivery Systems Market, by Technology, 2020-2027 (USD Million)

Table 9. North America: Transdermal (Percutaneous) Drug Delivery Systems Market, by Application, 2020-2027 (USD Million)

Table 10. US: Transdermal (Percutaneous) Drug Delivery Systems Market, by Product, 2020-2027 (USD Million)

Table 11. US: Transdermal (Percutaneous) Drug Delivery Systems Market, by Technology, 2020-2027 (USD Million)

Table 12. US: Transdermal (Percutaneous) Drug Delivery Systems Market, by Application, 2020-2027 (USD Million)

Table 13. Canada: Transdermal (Percutaneous) Drug Delivery Systems Market, by Product, 2020-2027 (USD Million)

Table 14. Canada: Transdermal (Percutaneous) Drug Delivery Systems Market, by Technology, 2020-2027 (USD Million)

Table 15. Canada: Transdermal (Percutaneous) Drug Delivery Systems Market, by Application, 2020-2027 (USD Million)

Table 16. Latin America: Transdermal (Percutaneous) Drug Delivery Systems Market, by Product, 2020-2027 (USD Million)

Table 17. Latin America: Transdermal (Percutaneous) Drug Delivery Systems Market, by Technology, 2020-2027 (USD Million)

Table 18. Latin America: Transdermal (Percutaneous) Drug Delivery Systems Market, by Application, 2020-2027 (USD Million)

Table 19. Europe: Transdermal (Percutaneous) Drug Delivery Systems Market, by Product, 2020-2027 (USD Million)

Table 20. Europe: Transdermal (Percutaneous) Drug Delivery Systems Market, by Technology, 2020-2027 (USD Million)

Table 21. Europe: Transdermal (Percutaneous) Drug Delivery Systems Market, by Application, 2020-2027 (USD Million)

Table 22. Western Europe: Transdermal (Percutaneous) Drug Delivery Systems Market, by Product, 2020-2027 (USD Million)

Table 23. Western Europe: Transdermal (Percutaneous) Drug Delivery Systems Market, by Technology, 2020-2027 (USD Million)

Table 24. Western Europe: Transdermal (Percutaneous) Drug Delivery Systems Market, by Application, 2020-2027 (USD Million)

Table 25. Eastern Europe: Transdermal (Percutaneous) Drug Delivery Systems Market, by Product, 2020-2027 (USD Million)

Table 26. Eastern Europe: Transdermal (Percutaneous) Drug Delivery Systems Market, by Technology, 2020-2027 (USD Million)

Table 27. Eastern Europe: Transdermal (Percutaneous) Drug Delivery Systems Market, by Application, 2020-2027 (USD Million)

Table 28. Asia-Pacific: Transdermal (Percutaneous) Drug Delivery Systems Market, by Product, 2020-2027 (USD Million)

Table 29. Asia-Pacific: Transdermal (Percutaneous) Drug Delivery Systems Market, by Technology, 2020-2027 (USD Million)

Table 30. Asia-Pacific: Transdermal (Percutaneous) Drug Delivery Systems Market, by Application, 2020-2027 (USD Million)

Table 31. Middle East & Africa: Transdermal (Percutaneous) Drug Delivery Systems Market, by Product, 2020-2027 (USD Million)

Table 32. Middle East & Africa: Transdermal (Percutaneous) Drug Delivery Systems Market, by Technology, 2020-2027 (USD Million)

Table 33. Middle East & Africa: Transdermal (Percutaneous) Drug Delivery Systems Market, by Application, 2020-2027 (USD Million)

LIST OF FIGURES

Figure 1. Research Process

Figure 2. Segmentation for Global Transdermal (Percutaneous) Drug Delivery Systems Market

Figure 3. Segmentation Market Dynamics for Global Transdermal (Percutaneous) Drug Delivery Systems Market

Figure 4. Global Transdermal (Percutaneous) Drug Delivery Systems Market Share, by Product, 2020

Figure 5. Global Transdermal (Percutaneous) Drug Delivery Systems Market Share, by Technology, 2020

Figure 6. Global Transdermal (Percutaneous) Drug Delivery Systems Market Share, by Application, 2020

Figure 7. Global Transdermal (Percutaneous) Drug Delivery Systems Market Share, by Region, 2020

Figure 8. North America: Transdermal (Percutaneous) Drug Delivery Systems Market Share, by Country, 2020

Figure 9. Europe: Transdermal (Percutaneous) Drug Delivery Systems Market Share, by Country, 2020

Figure 10. Asia-Pacific: Transdermal (Percutaneous) Drug Delivery Systems Market Share, by Country, 2020

Figure 11. Middle East & Africa: Transdermal (Percutaneous) Drug Delivery Systems Market Share, by Country, 2020

Figure 12. Global Transdermal (Percutaneous) Drug Delivery Systems Market: Company Share Analysis, 2020 (%)

Figure 13. Mylan N.V.: Key Financials

Figure 14. Mylan N.V.: Segmental Revenue

Figure 15. Mylan N.V.: Geographical Revenue

Figure 16. Hisamitsu Pharmaceutical Co., Inc.: Key Financials

Figure 17. Hisamitsu Pharmaceutical Co., Inc.: Segmental Revenue

Figure 18. Hisamitsu Pharmaceutical Co., Inc.: Geographical Revenue

Figure 19. Novartis International AG: Key Financials

Figure 20. Novartis International AG: Segmental Revenue

Figure 21. Novartis International AG: Geographical Revenue

Figure 22. Boehringer Ingelheim International GmbH: Key Financials

Figure 23. Boehringer Ingelheim International GmbH: Segmental Revenue

Figure 24. Boehringer Ingelheim International GmbH: Geographical Revenue

Figure 25. GlaxoSmithKline plc: Key Financials

Figure 26. GlaxoSmithKline plc: Segmental Revenue

Figure 27. GlaxoSmithKline plc: Geographical Revenue

Figure 28. Johnson & Johnson Services, Inc.: Key Financials

Figure 29. Johnson & Johnson Services, Inc.: Segmental Revenue

Figure 30. Johnson & Johnson Services, Inc.: Geographical Revenue

Figure 31. Endo Pharmaceuticals Inc.: Key Financials

Figure 32. Endo Pharmaceuticals Inc.: Segmental Revenue

Figure 33. Endo Pharmaceuticals Inc.: Geographical Revenue

Figure 34. UCB S.A.: Key Financials

Figure 35. UCB S.A.: Segmental Revenue

Figure 36. UCB S.A.: Geographical Revenue

Figure 37. Pfizer Inc.: Key Financials

Figure 38. Pfizer Inc.: Segmental Revenue

Figure 39. Pfizer Inc.: Geographical Revenue

Figure 40. Allergan plc: Key Financials

Figure 41. Allergan plc: Segmental Revenue

Figure 42. Allergan plc: Geographical Revenue

Figure 43. Actelion Pharmaceuticals Ltd: Key Financials

Figure 44. Actelion Pharmaceuticals Ltd: Segmental Revenue

Figure 45. Actelion Pharmaceuticals Ltd: Geographical Revenue

Figure 46. Noven Pharmaceuticals, Inc.: Key Financials

Figure 47. Noven Pharmaceuticals, Inc.: Segmental Revenue

Figure 48. Noven Pharmaceuticals, Inc.: Geographical Revenue



This table of content is tentative and subject to change as the research progresses.

Please Note:  Financial details of company cannot be provided if the information of the company is not available in public domain and or reliable source.

Transdermal Drug Delivery Systems Market